In 2024, it is estimated that there will have been around 81,610 new cases of kidney cancer diagnosed (52,380 in men and 29,230 in women)1. Early detection of kidney cancer is crucial for improving survival rates, with five-year survival reaching 70-94 percent for localized tumors2. Imaging tests, including computed tomography (CT) scans, are vital in detecting kidney cancer due to their sensitivity, detail, and non-invasive nature.
A computed tomography (CT) scan is a diagnostic imaging procedure that uses X-ray technology and computer processing to create detailed cross-sectional images of the body3. It produces more detailed images than standard X-rays, allowing healthcare professionals to visualize internal structures such as bones, muscles, organs, and blood vessels.
CT scans are advanced medical imaging techniques that use X-rays and computer processing to create detailed cross-sectional images of the body. The technology involves a rotating X-ray tube and detectors that measure X-ray attenuation through different tissues4. These measurements are then processed using tomographic reconstruction algorithms to produce virtual “slices” of the body.
The CT machine consists of a motorized table that moves the patient through a circular opening called the gantry5. Inside the gantry, an X-ray source and detector assembly rotate around the patient, typically completing a rotation in less than a second. As the X-rays pass through the body, detectors register the radiation that emerges, creating snapshots from various angles. The computer then reconstructs these snapshots into cross-sectional images or slices of the internal organs and tissues.
.jpeg)
CT scans are particularly useful in detecting kidney abnormalities and potential cancers:
For kidney cancer diagnosis, doctors might use a specific type of CT called “CT angiography” to get a better look at the blood vessels around the kidney7. Additionally, CT scans can guide biopsies and help monitor treatment effectiveness.
CT scans offer high accuracy and detailed imaging in kidney cancer detection.
As mentioned above, CT scans use X-rays and computer processing to create detailed cross-sectional images of the body, allowing for precise visualization of kidney tumors. The process involves:
Tumor characteristics: CT scans can reveal tumor size, shape, location, and density9.
CT scans are highly effective for kidney cancer detection, with a median sensitivity of 88 percent and a median specificity of 75 percent10. But how do they stack up to other imaging methods?
CT vs. MRI: Magnetic Resonance Imaging (MRI) machines have a similar sensitivity to CT (87.5 percent) and a slightly lower specificity (89 percent) in detecting kidney cancer. MRI also has superior soft tissue contrast, allowing for higher-resolution imaging. Furthermore, unlike CT scans, MRIs do not expose patients to ionizing radiation8,10. However, the time taken for an MRI is longer than that for a CT, and they are less widely available.
CT vs. Ultrasound: Ultrasound is less accurate than CT, especially for small tumors. However, it is useful for initial screening and cyst characterization. While it does not expose patients to ionizing radiation, it is limited in detecting small kidney tumors11.
CT scans remain the gold standard for kidney cancer detection due to their wide availability, rapid acquisition time, and high accuracy in tumor characterization.
Proper preparation is essential for a successful CT scan.
If your scan requires it, you may have to fast for four hours before your appointment time12. You can drink clear fluids and take medications as normal13. Diabetic patients can have a light snack if necessary but should avoid large meals. If contrast material is needed, you might be asked to drink water or a special liquid contrast.
You will likely be asked to change into a hospital gown for the scan. Remove any metal items, including jewelry, from the area being scanned. Wear comfortable, loose-fitting clothing to your appointment.
If your CT requires contrast, an IV line may be placed in your arm or hand to inject the contrast dye14. You might be given an oral contrast to drink, which helps highlight your digestive tract. Before contrast is administered, you should inform your healthcare provider if you have any allergies, especially to iodine or contrast materials.
You should inform your doctor if you’re pregnant or think you might be. Tell your healthcare provider about any medical conditions, recent illnesses, or medications you’re taking. If you’re taking metformin for diabetes, you may be asked to temporarily stop this medication15.
A CT scan is a quick and painless imaging procedure that provides detailed images of your internal organs and structures.
The entire CT scan process usually takes between 15 and 30 minutes, with the actual scanning time being 10 to 15 minutes. You’ll lie on your back on a table that moves through the CT scanner, which looks like a large doughnut. The table will slowly slide you into the scanner, and you’ll need to remain still during the imaging process.
As the table moves through the scanner, you’ll hear whirring or buzzing noises from the X-ray machine rotating around you. The radiographer will operate the scanner from another room but can see and communicate with you via an intercom. You may be asked to hold your breath briefly at certain points to ensure clear images.
If you feel anxious, inform the radiographer, who can advise you on staying calm. For those prone to claustrophobia, it’s reassuring to know that the CT scanner doesn’t completely enclose your body, reducing the likelihood of feeling confined.
CT scans are considered safe and use low levels of radiation16. The procedure is painless and non-invasive. While lying still might be uncomfortable for some, the scan itself doesn’t cause physical discomfort.
Remember, your radiographer ensures your comfort and safety throughout the procedure. Don’t hesitate to communicate any concerns you may have during the scan.
As mentioned above, CT scans demonstrate exceptional accuracy in detecting kidney cancer. It has the ability to detect and stage renal masses with up to 91 percent accuracy17. CT scans also excel at identifying kidney tumors in their early stages and can detect small renal masses before they become symptomatic18.
CT scans provide comprehensive information about kidney tumors, offering precise details on tumor size, shape, and location. CT scans can also differentiate between solid tumors and fluid-filled cysts and allow for accurate staging of the cancer and assessment of spread19.
CT scans are non-invasive and generally well-tolerated, requiring no surgical intervention for diagnosis. They can also be performed quickly, with actual scan times of 10 to 30 minutes.
CT scans serve multiple purposes in kidney cancer management, such as guiding biopsies and local treatments like cryotherapy and radiofrequency ablation20. They can also monitor treatment effectiveness and check for cancer recurrence. They can also be combined with other imaging techniques like CT angiography for enhanced visualization.
CT scans are generally safe, but it’s important to be aware of potential risks and contraindications.
Radiation exposure from medical imaging, such as CT scans, is a significant concern due to the potential risks associated with ionizing radiation21. Ionizing radiation can damage living tissues by removing electrons from atoms, which may increase cancer risk over time. To minimize these risks, low-dose CT (LDCT) scans have been developed. LDCT uses significantly less radiation than regular CT scans, making it a safer option for routine screenings.
Contrast agents enhance the visibility of internal structures in imaging. However, they can be contraindicated in patients with certain conditions, such as allergies to contrast materials or severe kidney impairment22. In the case of a kidney scan, intravenous contrast is most common, and a blood test might be done beforehand to check kidney function and ensure the safe use of contrast23.
CT scans are generally not recommended for pregnant women except in emergencies due to radiation exposure risks to the fetus24. Furthermore, CT scans may detect abnormalities that turn out to be benign, potentially leading to unnecessary follow-up procedures and anxiety.
Despite these risks and limitations, CT scans remain an important tool in kidney cancer detection and management, with the benefits often outweighing the risks.
Doctors typically recommend CT scans when patients experience specific symptoms that might indicate kidney cancer. These include blood in the urine, persistent side or lower back pain, unexplained lumps, significant weight loss, or ongoing fatigue25. Such symptoms warrant a comprehensive diagnostic investigation to rule out or confirm potential kidney abnormalities.
Individuals with a family history of kidney cancer or specific genetic syndromes are prime candidates for CT scan screenings. People with inherited conditions like von Hippel-Lindau disease or those with first-degree relatives diagnosed with kidney cancer may require more frequent and proactive imaging to detect potential tumors early26.
When initial diagnostic tests like ultrasounds, blood work, or X-rays produce unclear or suspicious results, physicians often turn to CT scans. These advanced imaging techniques provide detailed, cross-sectional views that can clarify ambiguous findings and help determine the next steps in diagnosis.
CT scans are highly effective in detecting various types of kidney cancer, including clear cell (ccRCC), chromophobe (chRCC), and papillary (pRCC) renal cell carcinomas, as well as onocytomas (ONC)27. However, while CT scans have a high accuracy rate, they may occasionally miss very small tumors or have difficulty distinguishing between benign and malignant growths definitively28.
For people with small kidney cancers under active surveillance, the frequency of screenings is typically every three months for the first year, every six months for the next two years, and once a year thereafter29. However, there is currently no widely recommended screening program for the general population.
Yes, you may need additional tests after a CT scan to confirm a diagnosis or gather more information. These could include:
CT scans are a cornerstone in the detection, diagnosis, and management of kidney cancer, offering unparalleled accuracy and detailed imaging capabilities. They are critical in identifying tumors early, staging cancer, guiding treatment, and monitoring progress. Despite minor risks, such as radiation exposure and contrast-related complications, the benefits of CT scans outweigh the limitations, making them an important tool in clinical practice. By enabling early and precise detection, CT scans improve patient outcomes and aid in the effective management of kidney cancer, supporting timely and informed decision-making in medical care.
If you want to be proactive about your health, why not book an Ezra Full-Body Plus scan? We combine MRI with LDCT to catch potential cancer earlier, leveraging AI through the screening process to make it more efficient, affordable, and faster.
1. Key Statistics About Kidney Cancer. Accessed January 8, 2025. https://www.cancer.org/cancer/types/kidney-cancer/about/key-statistics.html
2. Lewis G, Maxwell AP. Early diagnosis improves survival in kidney cancer. Practitioner. 2012;256(1748):13-16, 2.
3. Definition of CT scan - NCI Dictionary of Cancer Terms - NCI. February 2, 2011. Accessed December 9, 2024. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ct-scan
4. CT scan - Mayo Clinic. Accessed December 9, 2024. https://www.mayoclinic.org/tests-procedures/ct-scan/about/pac-20393675
5. Computed Tomography (CT). National Institute of Biomedical Imaging and Bioengineering. Accessed December 9, 2024. https://www.nibib.nih.gov/science-education/science-topics/computed-tomography-ct
6. Hsu WY, Lu CC, Hsu YY. Improving segmentation accuracy of CT kidney cancer images using adaptive active contour model. Medicine. 2020;99(47):e23083. doi:10.1097/MD.0000000000023083
7. Tests for Kidney Cancer | Kidney Cancer Diagnosis. Accessed January 8, 2025. https://www.cancer.org/cancer/types/kidney-cancer/detection-diagnosis-staging/how-diagnosed.html
8. van Oostenbrugge TJ, Fütterer JJ, Mulders PFA. Diagnostic Imaging for Solid Renal Tumors: A Pictorial Review. Kidney Cancer. 2(2):79-93. doi:10.3233/KCA-180028
9. O’Connor SD, Silverman SG, Khorasani RK. Renal Cancer at Unenhanced CT: Imaging Features, Detection Rates, and Outcomes. Abdom Radiol (NY). 2018;43(7):1756-1763. doi:10.1007/s00261-017-1376-0
10. Vogel C, Ziegelmüller B, Ljungberg B, et al. Imaging in Suspected Renal-Cell Carcinoma: Systematic Review. Clin Genitourin Cancer. 2019;17(2):e345-e355. doi:10.1016/j.clgc.2018.07.024
11. Gharaibeh M, Alzu’bi D, Abdullah M, et al. Radiology Imaging Scans for Early Diagnosis of Kidney Tumors: A Review of Data Analytics-Based Machine Learning and Deep Learning Approaches. Big Data and Cognitive Computing. 2022;6(1):29. doi:10.3390/bdcc6010029
12. CT scan. nhs.uk. October 18, 2017. Accessed December 9, 2024. https://www.nhs.uk/conditions/ct-scan/
13. Radiology (ACR) RS of NA (RSNA) and AC of. CT Colonography. Radiologyinfo.org. Accessed December 9, 2024. https://www.radiologyinfo.org/en/info/ct_colo
14. Rogers DC, Tadi P. Intravenous Contrast. In: StatPearls. StatPearls Publishing; 2024. Accessed December 9, 2024. http://www.ncbi.nlm.nih.gov/books/NBK557794/
15. Imperial College Healthcare. Having a CT Scan. Having a CT Scan - Information for Patients. 2019. Accessed December 9, 2024. https://www.imperial.nhs.uk/-/media/website/patient-information-leaflets/imaging/having-a-ct-scan.pdf?rev=a4168516b0374dbf9ea6214e676c0d79&sc_lang=en
16. Computed Tomography (CT) Scans and Cancer Fact Sheet - NCI. January 3, 2024. Accessed July 16, 2024. https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet
17. Nazim SM, Ather MH, Hafeez K, Salam B. Accuracy of multidetector CT scans in staging of renal carcinoma. International Journal of Surgery. 2011;9(1):86-90. doi:10.1016/j.ijsu.2010.07.304
18. Inamoto K, Takemura K, Tanaka S, Miura T, Ikoma F. Computed tomography in the detection of small renal cell carcinoma. Radiat Med. 1983;1(4):293-298.
19. Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology. 2007;243(2):445-450. doi:10.1148/radiol.2432060559
20. Ortiz-Alvarado O, Anderson JK. The role of radiologic imaging and biopsy in renal tumor ablation. World J Urol. 2010;28(5):551-557. doi:10.1007/s00345-010-0549-z
21. Health C for D and R. What are the Radiation Risks from CT? FDA. Published online March 11, 2018. Accessed December 9, 2024. https://www.fda.gov/radiation-emitting-products/medical-x-ray-imaging/what-are-radiation-risks-ct
22. British Society of Gastrointestinal and Abdominal Radiology (BSGAR). Standards for intravascular contrast agent administration to adult patients, Second edition. Published online 2010. Accessed January 9, 2025. https://www.bsgar.org/media/BFCR(10)4_Stand_contrast(3).pdf
23. Lee JK, Warshauer DM, Bush WH, McClennan BL, Choyke PL. Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol. 1995;30(12):700-705. doi:10.1097/00004424-199512000-00002
24. Albakri AA, Alzahrani MM, Alghamdi SH. Medical Imaging in Pregnancy: Safety, Appropriate Utilization, and Alternative Modalities for Imaging Pregnant Patients. Cureus. 16(2):e54346. doi:10.7759/cureus.54346
25. Signs and Symptoms of Kidney Cancer | Renal Cancer Signs. Accessed January 9, 2025. https://www.cancer.org/cancer/types/kidney-cancer/detection-diagnosis-staging/signs-and-symptoms.html
26. Early Signs of Kidney Cancer | Can Kidney Cancer Be Found Early? Accessed January 9, 2025. https://www.cancer.org/cancer/types/kidney-cancer/detection-diagnosis-staging/detection.html
27. Mahmud S, Abbas TO, Mushtak A, Prithula J, Chowdhury MEH. Kidney Cancer Diagnosis and Surgery Selection by Machine Learning from CT Scans Combined with Clinical Metadata. Cancers. 2023;15(12):3189. doi:10.3390/cancers15123189
28. Usher-Smith J, Simmons RK, Rossi SH, Stewart GD. Current evidence on screening for renal cancer. Nat Rev Urol. 2020;17(11):637-642. doi:10.1038/s41585-020-0363-3
29. Monitoring a kidney cancer (active surveillance). Accessed January 9, 2025. https://www.cancerresearchuk.org/about-cancer/kidney-cancer/treatment/monitoring
